NorthStrive Biosciences Announces The Filing of Two U.S. Patent Applications Targeting Microgravity-Induced Muscle Loss During Long-Duration Spaceflight
NorthStrive Biosciences, a subsidiary of PMGC Holdings Inc., announced the filing of two U.S. patent applications for its lead assets EL-22 and EL-32, aimed at preserving lean muscle mass during long-duration spaceflight by targeting muscle loss caused by microgravity. These filings extend the company's intellectual property portfolio beyond terres…